These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 25809711)
21. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds. Mishra B; Priyadarsini KI; Mohan H; Mugesh G Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452 [TBL] [Abstract][Full Text] [Related]
22. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Wagner G; Schuch G; Akerboom TP; Sies H Biochem Pharmacol; 1994 Sep; 48(6):1137-44. PubMed ID: 7945407 [TBL] [Abstract][Full Text] [Related]
23. Mechanistic investigations on the efficient catalytic decomposition of peroxynitrite by ebselen analogues. Bhabak KP; Vernekar AA; Jakka SR; Roy G; Mugesh G Org Biomol Chem; 2011 Jul; 9(14):5193-200. PubMed ID: 21629895 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of disulfides and diselenides by copper-catalyzed coupling reactions in water. Li Z; Ke F; Deng H; Xu H; Xiang H; Zhou X Org Biomol Chem; 2013 May; 11(18):2943-6. PubMed ID: 23538860 [TBL] [Abstract][Full Text] [Related]
25. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues. Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778 [TBL] [Abstract][Full Text] [Related]
26. Ebselen, a redox regulator containing a selenium atom, induces neurofilament M expression in cultured rat pheochromocytoma PC12 cells via activation of mitogen-activated protein kinase. Nishina A; Sekiguchi A; He Y; Koketsu M; Furukawa S J Neurosci Res; 2008 Feb; 86(3):720-5. PubMed ID: 17918745 [TBL] [Abstract][Full Text] [Related]
27. Diphenyl diselenide and analogs are substrates of cerebral rat thioredoxin reductase: a pathway for their neuroprotective effects. de Freitas AS; Rocha JB Neurosci Lett; 2011 Sep; 503(1):1-5. PubMed ID: 21839146 [TBL] [Abstract][Full Text] [Related]
28. Ebselen-binding equilibria between plasma and target proteins. Ullrich V; Weber P; Meisch F; von Appen F Biochem Pharmacol; 1996 Jul; 52(1):15-9. PubMed ID: 8678900 [TBL] [Abstract][Full Text] [Related]
29. Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration. Landgraf AD; Alsegiani AS; Alaqel S; Thanna S; Shah ZA; Sucheck SJ ACS Chem Neurosci; 2020 Oct; 11(19):3008-3016. PubMed ID: 32840996 [TBL] [Abstract][Full Text] [Related]
30. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Nogueira CW; Rocha JB Arch Toxicol; 2011 Nov; 85(11):1313-59. PubMed ID: 21720966 [TBL] [Abstract][Full Text] [Related]
31. Multifunctional Antioxidants: Regenerable Radical-Trapping and Hydroperoxide-Decomposing Ebselenols. Kumar S; Yan J; Poon JF; Singh VP; Lu X; Karlsson Ott M; Engman L; Kumar S Angew Chem Int Ed Engl; 2016 Mar; 55(11):3729-33. PubMed ID: 26879742 [TBL] [Abstract][Full Text] [Related]
32. Ebselen could be used as anti-inflammatory Nox inhibitor. Future Med Chem; 2012 Aug; 4(12):1533-5. PubMed ID: 22917242 [No Abstract] [Full Text] [Related]
33. Simultaneous induction of interferon gamma and tumor necrosis factor alpha by different seleno-organic compounds in human peripheral blood leukocytes. Piasecki E; Inglot AD; Zielińska-Jenczylik J; Młochowski J; Syper L Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):229-34. PubMed ID: 1300988 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, structure, and glutathione peroxidase-like activity of amino acid containing ebselen analogues and diaryl diselenides. Selvakumar K; Shah P; Singh HB; Butcher RJ Chemistry; 2011 Nov; 17(45):12741-55. PubMed ID: 21956838 [TBL] [Abstract][Full Text] [Related]
35. A superoxide anion-scavenger, 1,3-selenazolidin-4-one suppresses serum deprivation-induced apoptosis in PC12 cells by activating MAP kinase. Nishina A; Kimura H; Kozawa K; Sommen G; Nakamura T; Heimgartner H; Koketsu M; Furukawa S Toxicol Appl Pharmacol; 2011 Dec; 257(3):388-95. PubMed ID: 22001386 [TBL] [Abstract][Full Text] [Related]
37. The reaction of 2-(methylseleno)benzanilide with peroxynitrite. Masumoto H; Sies H Chem Res Toxicol; 1996; 9(7):1057-62. PubMed ID: 8902259 [TBL] [Abstract][Full Text] [Related]
38. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen. Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170 [TBL] [Abstract][Full Text] [Related]
39. Seleno-organic compounds as immunostimulants: an approach to the structure-activity relationship. Inglot AD; Młochowski J; Zielińska-Jenczylik J; Piasecki E; Ledwoń TK; Kloc K Arch Immunol Ther Exp (Warsz); 1996; 44(1):67-75. PubMed ID: 8874773 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antioxidant activity of peptide-based ebselen analogues. Satheeshkumar K; Mugesh G Chemistry; 2011 Apr; 17(17):4849-57. PubMed ID: 21400619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]